Standout Papers

Nirmatrelvir-resistant SARS-CoV-2 variants with high fitness in an infectious cell culture system 2022 2026 2023 2024126
  1. Nirmatrelvir-resistant SARS-CoV-2 variants with high fitness in an infectious cell culture system (2022)
    Yuyong Zhou, Karen Anbro Gammeltoft et al. Science Advances

Immediate Impact

3 from Science/Nature 37 standout
Sub-graph 1 of 13

Citing Papers

Design of a SARS-CoV-2 papain-like protease inhibitor with antiviral efficacy in a mouse model
2024 StandoutScience
Nanotechnology’s frontier in combatting infectious and inflammatory diseases: prevention and treatment
2024 Standout
7 intermediate papers

Works of Anna Offersgaard being referenced

Inactivated whole hepatitis C virus vaccine employing a licensed adjuvant elicits cross-genotype neutralizing antibodies in mice
2022
Nirmatrelvir-resistant SARS-CoV-2 variants with high fitness in an infectious cell culture system
2022 Standout

Author Peers

Author Last Decade Papers Cites
Anna Offersgaard 215 67 76 94 94 18 382
Adeline Danneels 139 34 35 85 30 12 340
Hamed Gouklani 188 100 110 178 49 24 444
Shuqi Xiao 176 22 41 83 40 17 429
Tianhong Zhang 173 12 78 154 47 13 410
N. Mehzabeen 167 23 38 148 50 18 362
Shweta Kumari 187 14 41 122 54 32 412
G.J. Lockbaum 243 31 57 158 158 21 425
Jérôme Deval 228 35 115 138 44 12 387
Ornjira Aruksakunwong 119 12 146 220 39 17 374
Thibault Tubiana 81 20 19 195 45 19 343

All Works

Loading papers...

Rankless by CCL
2026